NVIV Annual Current Liabilities
$2.47 M
-$144.00 K-5.51%
31 December 2022
Summary:
As of February 5, 2025, NVIV annual total current liabilities is $2.47 million, with the most recent change of -$144.00 thousand (-5.51%) on December 31, 2022. During the last 3 years, it has fallen by -$195.00 thousand (-7.32%).NVIV Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVIV Quarterly Current Liabilities
$666.00 K
-$702.00 K-51.32%
30 September 2023
Summary:
As of February 5, 2025, NVIV quarterly total current liabilities is $666.00 thousand, with the most recent change of -$702.00 thousand (-51.32%) on September 30, 2023. Over the past year, it has dropped by -$1.83 million (-73.37%).NVIV Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVIV Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -73.4% |
| 3 y3 years | -7.3% | -64.3% |
| 5 y5 years | -20.7% | -77.3% |
NVIV Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -93.3% | -98.2% |
InVivo Therapeutics Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $666.00 K(-51.3%) |
| June 2023 | - | $1.37 M(-17.1%) |
| Mar 2023 | - | $1.65 M(-33.1%) |
| Dec 2022 | $2.47 M(-5.5%) | $2.47 M(-1.3%) |
| Sept 2022 | - | $2.50 M(+3.9%) |
| June 2022 | - | $2.41 M(+15.9%) |
| Mar 2022 | - | $2.08 M(-20.5%) |
| Dec 2021 | $2.61 M(+32.5%) | $2.61 M(+30.0%) |
| Sept 2021 | - | $2.01 M(+11.8%) |
| June 2021 | - | $1.80 M(+21.9%) |
| Mar 2021 | - | $1.48 M(-25.2%) |
| Dec 2020 | $1.97 M(-25.9%) | $1.97 M(+5.6%) |
| Sept 2020 | - | $1.87 M(+4.2%) |
| June 2020 | - | $1.79 M(-4.2%) |
| Mar 2020 | - | $1.87 M(-29.7%) |
| Dec 2019 | $2.66 M(+20.8%) | $2.66 M(+25.2%) |
| Sept 2019 | - | $2.13 M(+11.6%) |
| June 2019 | - | $1.91 M(-8.8%) |
| Mar 2019 | - | $2.09 M(-5.3%) |
| Dec 2018 | $2.21 M(-29.1%) | $2.21 M(-24.9%) |
| Sept 2018 | - | $2.94 M(-88.6%) |
| June 2018 | - | $25.71 M(+526.3%) |
| Mar 2018 | - | $4.11 M(+31.9%) |
| Dec 2017 | $3.11 M(-35.8%) | $3.11 M(-12.8%) |
| Sept 2017 | - | $3.57 M(-8.0%) |
| June 2017 | - | $3.88 M(-5.5%) |
| Mar 2017 | - | $4.11 M(-15.2%) |
| Dec 2016 | $4.85 M(+46.4%) | $4.85 M(-11.9%) |
| Sept 2016 | - | $5.50 M(+19.1%) |
| June 2016 | - | $4.62 M(-3.4%) |
| Mar 2016 | - | $4.79 M(+44.6%) |
| Dec 2015 | $3.31 M(-62.3%) | $3.31 M(-40.3%) |
| Sept 2015 | - | $5.54 M(-46.4%) |
| June 2015 | - | $10.34 M(-31.6%) |
| Mar 2015 | - | $15.12 M(+72.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $8.78 M(+287.3%) | $8.78 M(+82.4%) |
| Sept 2014 | - | $4.82 M(-38.1%) |
| June 2014 | - | $7.78 M(+286.4%) |
| Mar 2014 | - | $2.01 M(-11.2%) |
| Dec 2013 | $2.27 M(-86.5%) | $2.27 M(+8.3%) |
| Sept 2013 | - | $2.09 M(+34.5%) |
| June 2013 | - | $1.56 M(-94.1%) |
| Mar 2013 | - | $26.38 M(+57.1%) |
| Dec 2012 | $16.79 M(-54.3%) | $16.79 M(+30.7%) |
| Sept 2012 | - | $12.85 M(-47.6%) |
| June 2012 | - | $24.54 M(-17.6%) |
| Mar 2012 | - | $29.79 M(-18.9%) |
| Dec 2011 | $36.74 M(+227.1%) | $36.74 M(+624.0%) |
| Sept 2011 | - | $5.07 M(-48.4%) |
| June 2011 | - | $9.84 M(-10.1%) |
| Mar 2011 | - | $10.95 M(>+9900.0%) |
| Dec 2010 | $11.23 M(>+9900.0%) | - |
| Sept 2010 | - | $105.50 K(+4.7%) |
| June 2010 | - | $100.80 K(+334.5%) |
| Mar 2010 | - | $23.20 K(+41.5%) |
| Mar 2010 | $23.20 K(-50.7%) | - |
| Dec 2009 | - | $16.40 K(+59.2%) |
| Sept 2009 | - | $10.30 K(-12.0%) |
| June 2009 | - | $11.70 K(-75.2%) |
| Mar 2009 | $47.10 K(+842.0%) | $47.10 K(+412.0%) |
| Dec 2008 | - | $9200.00(+46.0%) |
| Sept 2008 | - | $6300.00(-25.0%) |
| June 2008 | - | $8400.00(+68.0%) |
| Mar 2008 | $5000.00(+127.3%) | $5000.00(-23.1%) |
| Dec 2007 | - | $6500.00(>+9900.0%) |
| Sept 2007 | - | $0.00(-100.0%) |
| June 2007 | - | $3900.00(+77.3%) |
| Mar 2007 | $2200.00(-90.9%) | $2200.00(-57.7%) |
| Dec 2006 | - | $5200.00(-38.1%) |
| Sept 2006 | - | $8400.00(-65.4%) |
| Mar 2006 | $24.30 K | $24.30 K |
FAQ
- What is InVivo Therapeutics Holdings annual total current liabilities?
- What is the all time high annual current liabilities for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings annual current liabilities year-on-year change?
- What is InVivo Therapeutics Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings quarterly current liabilities year-on-year change?
What is InVivo Therapeutics Holdings annual total current liabilities?
The current annual current liabilities of NVIV is $2.47 M
What is the all time high annual current liabilities for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high annual total current liabilities is $36.74 M
What is InVivo Therapeutics Holdings annual current liabilities year-on-year change?
Over the past year, NVIV annual total current liabilities has changed by -$144.00 K (-5.51%)
What is InVivo Therapeutics Holdings quarterly total current liabilities?
The current quarterly current liabilities of NVIV is $666.00 K
What is the all time high quarterly current liabilities for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high quarterly total current liabilities is $36.74 M
What is InVivo Therapeutics Holdings quarterly current liabilities year-on-year change?
Over the past year, NVIV quarterly total current liabilities has changed by -$1.83 M (-73.37%)